Follow-The-Filings

Security

Black Diamond Therapeutics I · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 new max 0.0% (Renaissance Technologies LLC)

owners 8
max % 0.0%
tracked value $14M
qoq N 1 A 2 R 4

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 1,643,747 $4M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% 2,188,857 $5M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 836,266 $2M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 510,811 $1M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 502,652 $1M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 363,921 $775 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 134,979 $288 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 100,985 $215 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$82.44M -$69.68M $22.37M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $134.03M $101.18M $132.44M
Total non-current assets * $24.53M $21.46M $10.57M
Total assets $158.57M $122.64M $143.01M
Total current liabilities $19.65M $20.57M $15.73M
Total non-current liabilities * $22.18M $18.78M $15.07M
Total equity $116.74M $83.28M $112.21M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$66.72M -$62.3M $29.61M
Cash from investing $16.35M $16.97M -$44.9M
Cash from financing $71.93M $25.55M -$146,000
Net change in cash $21.56M -$19.79M -$15.44M

ownership over time

filing count by report period · click a bar for that quarter’s holders